| Financial Year |
March 31 2023 |
| Monetary Funds |
678,730,280.02 |
| Held-for-trading Financial Assets |
123,815,460.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
191,943,883.54 |
| Advances to Suppliers |
47,052,970.38 |
| Other Receivables |
14,419,032.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,505,572,730.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
106,354,251.09 |
| Total Current Assets |
2,667,888,608.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
58,067,884.42 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
128,938,910.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
52,908,075.23 |
| Deferred Income Tax Assets |
99,316,164.83 |
| Other Non-Current Assets |
37,981,512.49 |
| Sub-Total of Non-Current Assets |
677,551,909.67 |
| Total Assets |
3,345,440,518.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,815,630.23 |
| Accounts Payable |
230,641,092.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,988,301.92 |
| Taxes Payable |
3,412,781.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
77,011,067.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,785,529.92 |
| Other Current Liabilities |
107,910.63 |
| Sub-Total of Current Liabilities |
401,856,111.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,451,587.60 |
| Total Liabilities |
426,307,699.24 |
| Paid-In Capital(Or Share Stock) |
417,765,200.00 |
| Capital Surplus |
1,444,219,145.96 |
| Surplus Reserve |
177,690,934.30 |
| LESS:Treasury Stock |
72,682,848.00 |
| Undistributed Profits |
951,826,972.89 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,919,132,819.04 |
| Owner's Equity（Stockholder's Equity） |
2,919,132,819.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,345,440,518.28 |
